Healthcare -
Biotechnology - NASDAQ - US
$ 9.25
-0.213 %
$ 646 M
Market Cap
-0.91
P/E
PHAT - LONG-TERM DEBT
Long-term Debt PHAT - Phathom Pharmaceuticals, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR